| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/12/1999 | EP0914423A2 Inhibition of hiv-1 replication by antisense rna expression |
| 05/12/1999 | EP0914422A1 Mammalian genes involved in viral infection and tumor suppression |
| 05/12/1999 | EP0914421A2 Hepatitis c virus ribozymes |
| 05/12/1999 | EP0914417A2 Human dnase ii |
| 05/12/1999 | EP0914414A1 Laminin 5 for growth of pancreatic islet cells |
| 05/12/1999 | EP0914346A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FC$g(a) RECEPTOR ANTIBODIES |
| 05/12/1999 | EP0914345A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 05/12/1999 | EP0914339A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 05/12/1999 | EP0914334A1 Process and intermediates for the synthesis of lhrh antagonists |
| 05/12/1999 | EP0914333A1 Peptide derivatives |
| 05/12/1999 | EP0914332A1 Isoquinolines useful as analgesics |
| 05/12/1999 | EP0914331A1 Neuroactive peptides |
| 05/12/1999 | EP0914330A1 Novel compounds |
| 05/12/1999 | EP0914328A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE |
| 05/12/1999 | EP0914327A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE |
| 05/12/1999 | EP0914322A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production |
| 05/12/1999 | EP0914319A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 05/12/1999 | EP0914168A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides |
| 05/12/1999 | EP0914166A1 Methods of terminal sterilization of biological products |
| 05/12/1999 | EP0914165A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
| 05/12/1999 | EP0914164A1 Compounds that interfere with dna replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds |
| 05/12/1999 | EP0914163A1 Novel processes implementing selective immune down regulation (sidr) |
| 05/12/1999 | EP0914161A2 Chitosan - related compositions and methods for delivery of nucleic acids into a cell |
| 05/12/1999 | EP0914160A2 Hydrophobic carbomer complex compositions |
| 05/12/1999 | EP0914158A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity |
| 05/12/1999 | EP0914157A1 Anti-tnf antibodies and methotrexate in the treatment of autoimmune disease |
| 05/12/1999 | EP0914153A1 Multivalent dtp-polio vaccines |
| 05/12/1999 | EP0914150A1 Recombinant neospora antigens and their uses |
| 05/12/1999 | EP0914146A1 Morphogen treatment for chronic renal failure |
| 05/12/1999 | EP0914144A1 Therapeutic uses of bpi protein products for human meningococcemia |
| 05/12/1999 | EP0914140A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof |
| 05/12/1999 | EP0914138A1 Complex preparations characterised by a betain content |
| 05/12/1999 | EP0914137A2 In ovo antibiotic and microbial treatment to diminish salmonellae populations in avians |
| 05/12/1999 | EP0914136A1 Methods of enhancing lean tissue mass and bone mineral content and compositions therefor |
| 05/12/1999 | EP0914135A1 Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy |
| 05/12/1999 | EP0914133A1 Methods for cell mobilization using in vivo treatment with hyaluronan (ha) |
| 05/12/1999 | EP0914132A1 Eutrophic drug compositions based on transferrin glycans |
| 05/12/1999 | EP0914130A2 Novel anti-viral compounds |
| 05/12/1999 | EP0914129A1 Use of aspirochlorine or derivatives thereof as immunosuppressive agents |
| 05/12/1999 | EP0914128A1 Formulation and method for treating congestive heart failure |
| 05/12/1999 | EP0914127A2 Antifungal composition with enhanced bioavailability |
| 05/12/1999 | EP0914126A1 Sustained release sufentanil compositions |
| 05/12/1999 | EP0914125A1 Hiv protease inhibitors useful for the treatment of aids |
| 05/12/1999 | EP0914124A1 ANTITHROMBOTIC AND ANTIATHEROGENIC PHARMACEUTICAL COMPOSITION INCLUDING A THIENOPYRIDINE DERIVATIVE AND AN HMG-CoA-REDUCTASE INHIBITOR |
| 05/12/1999 | EP0914122A1 Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
| 05/12/1999 | EP0914121A1 Medicaments for ameliorating endothelial cell activation |
| 05/12/1999 | EP0914120A1 Anti-viral compounds |
| 05/12/1999 | EP0914119A2 Solid oral dosage forms of valsartan |
| 05/12/1999 | EP0914118A1 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 05/12/1999 | EP0914117A1 Combination of ropinirole and l-dopa for use in the treatment of parkinson's disease |
| 05/12/1999 | EP0914116A1 Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere |
| 05/12/1999 | EP0914115A1 Methods of providing neuroprotection |
| 05/12/1999 | EP0914114A1 Methods of treating type i hypersensitivity using monophosphoryl lipid a |
| 05/12/1999 | EP0914113A1 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin |
| 05/12/1999 | EP0914112A1 Improvement of male fertility with antioxidants and/or polyunsaturated fatty acids |
| 05/12/1999 | EP0914111A2 Method for the prevention and treatment of cachexia and anorexia |
| 05/12/1999 | EP0914110A1 Method of modulating microcirculation |
| 05/12/1999 | EP0914109A1 Composition of pyruvate and protein and method for increasing protein concentration in a mammal |
| 05/12/1999 | EP0914108A1 Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal |
| 05/12/1999 | EP0914106A1 Pharmaceutical products containing a complex of an amide-type local anesthetic and a polyacrylate |
| 05/12/1999 | EP0914105A1 Topical medicament comprising phenolic biocide and choline |
| 05/12/1999 | EP0914104A1 Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
| 05/12/1999 | EP0914103A1 Treatment of a hemoglobinopathy |
| 05/12/1999 | EP0914102A1 Compositions and methods for treating or preventing diseases of body passageways |
| 05/12/1999 | EP0914101A2 Transdermal therapeutic systems |
| 05/12/1999 | EP0914100A1 Oral composition comprising a triazole antifungal compound |
| 05/12/1999 | EP0914099A1 Oral coated active drugs |
| 05/12/1999 | EP0914098A1 Multi-layered osmotic device |
| 05/12/1999 | EP0914097A2 Composition and dosage form comprising opioid antagonist |
| 05/12/1999 | EP0914096A1 Microparticles and their use in wound therapy |
| 05/12/1999 | EP0914091A2 Ethene containing solutions and use thereof in methods of therapy or prophylaxis |
| 05/12/1999 | EP0914090A1 Antioxidant and/or antielastase composition based on lupine oil |
| 05/12/1999 | EP0914089A1 Use of lipophilic antioxidant compounds to prevent retinoid induced, uva-mediated oxidative reactions |
| 05/12/1999 | EP0914078A1 The use of l-lysine in the treatment of hair loss |
| 05/12/1999 | EP0914041A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
| 05/12/1999 | EP0914040A1 Antimicrobial composition and methods of use therefor |
| 05/12/1999 | EP0883398A4 Method of inhibiting photoaging of skin |
| 05/12/1999 | EP0808162B1 Use of carbazole compounds for the manufacture of a medicament for the treatment of congestive heart failure |
| 05/12/1999 | EP0799237B1 Vitamin b 12-containing sallow thorn concentrates or extracts |
| 05/12/1999 | EP0789559B1 Pharmaceutical composition containing a fusible carrier and method for producing the same |
| 05/12/1999 | EP0772438B1 Use of benzothiophenes for the preparation of a medicament for reducing scarring in wound healing |
| 05/12/1999 | EP0751940B1 Sesquiterpenic derivatives |
| 05/12/1999 | EP0735888A4 Purine compositions and methods for administration |
| 05/12/1999 | EP0733067B1 N-terminally chemically modified protein compositions and methods |
| 05/12/1999 | EP0722454B1 Stable solvates of avermectin compounds |
| 05/12/1999 | EP0722313B1 Viscoelastic compositions of fluorinated organic compounds |
| 05/12/1999 | EP0696281B1 Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives |
| 05/12/1999 | EP0654037B1 Antiretroviral enantiomeric nucleotide analogs |
| 05/12/1999 | EP0636020B1 A pharmaceutical carrier system containing defined lipids |
| 05/12/1999 | EP0628046B1 Triazolopyrimidin derivatives as antiotensin ii receptor antagonists |
| 05/12/1999 | EP0627900B1 Use of injectable collagen biomaterials for the repair and augmentation of the anal sphincters |
| 05/12/1999 | DE3745135C2 PAF acether binding site inhibitors |
| 05/12/1999 | DE19749413A1 Neuartige Sophoroselipide, Verfahren zu deren Herstellung und Verwendung Sophoroselipids novel, processes for their preparation and use |
| 05/12/1999 | DE19749096A1 Nebenwirkungsarmer nicht-steroidaler Entzündungshemmer oder COX-II-Hemmer Less adverse effects of non-steroidal anti-inflammatory drug or Cox-II inhibitor |
| 05/12/1999 | CN1216584A Immunity to trypanosomatids species |
| 05/12/1999 | CN1216582A Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases |
| 05/12/1999 | CN1216551A Novel peptides suitable for use in antigen specific immunosuppressive therapy |
| 05/12/1999 | CN1216549A Antipathogenic peptides and compositions comprising them |
| 05/12/1999 | CN1216547A Proton pump inhibitor |
| 05/12/1999 | CN1216546A Thienopyridine derivatives and their use |